Research Center
Research center status
JW Sinyak has incorporated JW creagene as its subsidiary in 2009, leading the development of new immune - based treatments.
-
Sungnam-si, Gyeonggi
JW Creagene
Core foundation technique :
Immune cell vaccine- - Dendritic cell vaccine
- - Cytoplasmic transduction peptide technology (CTP)
- - Protein manufacturing techniques